Vertex Pharmaceuticals

VRTX · Health Care

Sustainability score

54.4Rank 172 overall / 16 in Health Care

Vertex Pharmaceuticals's distance from the ideal is driven mostly by Asset turnover and ESG risk score. It sits closest to the frontier on Net debt / EBITDA.

66th percentile of the index, 74th percentile of Health Care

Environmental

Social

Financial/Operational

Distance-to-ideal decomposition

Emissions intensity

15%

ESG risk score

20%

Controversy level

Asset turnover

45%

Net margin

FCF margin

11%

Net debt / EBITDA

Pillar weight shares: Environmental 24%, Social 23%, Financial/Operational 53%

Generating AI analysis...

Net-zero scenario

VRTX · Vertex Pharmaceuticals

Middle · middle 60% of Health Care · score 64.2 · rank 41/59

Cleanup cost: 0.00 yrs · n/a; Sector median 0.00 yrs
Revenue at risk: 0%; Sector median 0%
Revenue upside: 0%; Sector median 0%
Can it pay: -0.8x debt load; FCF margin 30% · sector median 2.1x

Verdict: SELLNo position to stressData: estimatedHeld at benchmark

Cleanup bill by source

Purchased electricity	n/a
On-site fuel combustion	n/a
Vehicle fleets	n/a
Process emissions	n/a
Fugitive emissions	n/a

Why

Benchmark: burden 0.00 years of earnings (sector median 0.00 years), fossil revenue 0%, beneficiary revenue 0%, net debt/EBITDA -0.8x; largest gaps to the sector ideal: transition burden and leverage vs sector target.

Vertex Pharmaceuticals

Sustainability score

Net-zero scenario

VRTX · Vertex Pharmaceuticals

Cleanup bill by source

Why

Health Care peers

Key takeaways

Explanation

Vertex Pharmaceuticals

Sustainability score

Net-zero scenario

VRTX · Vertex Pharmaceuticals

Cleanup bill by source

Why

Health Care peers

Key takeaways

Explanation